Skip to content

A randomized controlled study of percutaneous acupoint electrical stimulation combined with aromatherapy in the prevention and treatment of postoperative nausea and vomiting in patients with microvascular decompression

A randomized controlled study of percutaneous acupoint electrical stimulation combined with aromatherapy in the prevention and treatment of postoperative nausea and vomiting in patients with microvascular decompression

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400079518
Enrollment
Unknown
Registered
2024-01-05
Start date
2024-01-08
Completion date
Unknown
Last updated
2024-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postoperative nausea and vomiting

Interventions

Acupuncture point stimulation group:Before the start of anesthesia, electronic acupuncture therapy (Huatuo brand SDZ-III type) was used to perform TEAS on bilateral Zusanli acupoints and bilateral Nei
Lemon essential oil inhalation group:After the patient s tracheal tube is removed from the PACU, soak lemon essential oil in gauze and cover the patient s mouth and nose, continuously sniffing the odo
And inhale lemon essential oil for 30 minutes on the morning and afternoon of the first postoperative day.
Joint intervention group:Before the start of anesthesia, electronic acupuncture therapy (Huatuo brand SDZ-III type) was used to perform TEAS on bilateral Zusanli acupoints and bilateral Neiguan acupoi
Blank control group:Anesthesia induction and anesthesia maintenance are routinely performed, conventional drugs for the prevention and treatment of PONV are given, and other non-drug therapies for PON

Sponsors

Department of Anesthesiology, the First Affiliated Hospital of University of Science and Technology of China (Anhui Provincial Hospital)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Patients with facial muscle spasm or trigeminal neuralgia who are scheduled for microvascular decompression 2. Age: 18~70 years old; 3. Those without TEAS contraindications, such as skin allergies, ulcers, infections, etc. 4. Those who are allergic to non-lemon odor or have no ability to smell 5. Able to understand and sign the informed consent form, and cooperate with the completion of intervention and evaluation.

Exclusion criteria

Exclusion criteria: (1) Those who use antiemetic drugs 24 hours before surgery; (2) Those who have recently undergone acupuncture treatment; (3) Patients with gastrointestinal system diseases; (4) Patients with a history of drug addiction, mental illness or epilepsy; (5) Serious respiratory, circulatory and nervous system diseases.

Design outcomes

Primary

MeasureTime frame
Incidence of postoperative nausea and vomiting;

Secondary

MeasureTime frame
Postoperative demand for antiemetic drugs;visual analogue pain scale;

Countries

China

Contacts

Public ContactKang Fang

Department of Anesthesiology, the First Affiliated Hospital of University of Science and Technology of China (Anhui Provincial Hospital)

kangfang199771@163.com+86 181 5512 7799

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026